The function of β2-glycoprotein I in angiogenesis and its in vivo distribution in tumor xenografts

Arum Tri Wahyuningsih, Lianhua Shen, Kazuko Kobayashi, Takanori Sasaki, Fumiaki Takenaka, Takahisa Hanada, Masaru Akehi, Akiya Akahoshi, Eiichi Ozeki, Eiji Ando, Eiji Matsuura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a relatively low concentration, and an antiangiogenic property at a high concentration. Here we investigated the functions of βi 2GPI and nβ2GPI in vascular endothelial growth factor (VEGF)-A-induced endothelial cell proliferation and tube formation. We used noninvasive PET imaging to analyze the in vivo distribution of intravenously injected β2GPI variants in tumor lesions in mice. iβ2GPI was incubated with plasmin to obtain nβ2GPI, and its N-terminal sequence was analyzed. nβ2GPI had at least one other cleavage site upstream of the β2GPI's domain V, whereas the former plasmin-cleavage site locates between K317 and T318. Both of intact and nicked β2GPI significantly inhibited the VEGF-A-induced cell proliferation and the tube formation of human umbilical vein endothelial cells (HUVECs). PET imaging visualized considerably distributed intensities of all tested β2GPI variants in tumor lesions of pancreatic tumor cell-xenografts. These results indicate that β2GPI may be physiologically and pathophysiologically important in the regulation of not only coagulation and fibrinolysis, but also angiogenesis.

Original languageEnglish
Pages (from-to)13-24
Number of pages12
JournalActa Medica Okayama
Volume70
Issue number1
Publication statusPublished - 2016

Fingerprint

Heterografts
Tumors
Glycoproteins
Fibrinolysin
Endothelial cells
Cell proliferation
Fibrinolysis
Coagulation
Vascular Endothelial Growth Factor A
Cell Proliferation
Imaging techniques
Neoplasms
Human Umbilical Vein Endothelial Cells
Endothelial Cells
Cells

Keywords

  • Angiogenesis
  • Positron emission tomography (PET) imaging
  • Vascular endothelial growth factor-A (VEGF-A)
  • β2-glycoprotein I (β2GPI)

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The function of β2-glycoprotein I in angiogenesis and its in vivo distribution in tumor xenografts. / Wahyuningsih, Arum Tri; Shen, Lianhua; Kobayashi, Kazuko; Sasaki, Takanori; Takenaka, Fumiaki; Hanada, Takahisa; Akehi, Masaru; Akahoshi, Akiya; Ozeki, Eiichi; Ando, Eiji; Matsuura, Eiji.

In: Acta Medica Okayama, Vol. 70, No. 1, 2016, p. 13-24.

Research output: Contribution to journalArticle

Wahyuningsih, Arum Tri ; Shen, Lianhua ; Kobayashi, Kazuko ; Sasaki, Takanori ; Takenaka, Fumiaki ; Hanada, Takahisa ; Akehi, Masaru ; Akahoshi, Akiya ; Ozeki, Eiichi ; Ando, Eiji ; Matsuura, Eiji. / The function of β2-glycoprotein I in angiogenesis and its in vivo distribution in tumor xenografts. In: Acta Medica Okayama. 2016 ; Vol. 70, No. 1. pp. 13-24.
@article{b539d35eaaf04204aba62c916367be93,
title = "The function of β2-glycoprotein I in angiogenesis and its in vivo distribution in tumor xenografts",
abstract = "Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a relatively low concentration, and an antiangiogenic property at a high concentration. Here we investigated the functions of βi 2GPI and nβ2GPI in vascular endothelial growth factor (VEGF)-A-induced endothelial cell proliferation and tube formation. We used noninvasive PET imaging to analyze the in vivo distribution of intravenously injected β2GPI variants in tumor lesions in mice. iβ2GPI was incubated with plasmin to obtain nβ2GPI, and its N-terminal sequence was analyzed. nβ2GPI had at least one other cleavage site upstream of the β2GPI's domain V, whereas the former plasmin-cleavage site locates between K317 and T318. Both of intact and nicked β2GPI significantly inhibited the VEGF-A-induced cell proliferation and the tube formation of human umbilical vein endothelial cells (HUVECs). PET imaging visualized considerably distributed intensities of all tested β2GPI variants in tumor lesions of pancreatic tumor cell-xenografts. These results indicate that β2GPI may be physiologically and pathophysiologically important in the regulation of not only coagulation and fibrinolysis, but also angiogenesis.",
keywords = "Angiogenesis, Positron emission tomography (PET) imaging, Vascular endothelial growth factor-A (VEGF-A), β2-glycoprotein I (β2GPI)",
author = "Wahyuningsih, {Arum Tri} and Lianhua Shen and Kazuko Kobayashi and Takanori Sasaki and Fumiaki Takenaka and Takahisa Hanada and Masaru Akehi and Akiya Akahoshi and Eiichi Ozeki and Eiji Ando and Eiji Matsuura",
year = "2016",
language = "English",
volume = "70",
pages = "13--24",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",

}

TY - JOUR

T1 - The function of β2-glycoprotein I in angiogenesis and its in vivo distribution in tumor xenografts

AU - Wahyuningsih, Arum Tri

AU - Shen, Lianhua

AU - Kobayashi, Kazuko

AU - Sasaki, Takanori

AU - Takenaka, Fumiaki

AU - Hanada, Takahisa

AU - Akehi, Masaru

AU - Akahoshi, Akiya

AU - Ozeki, Eiichi

AU - Ando, Eiji

AU - Matsuura, Eiji

PY - 2016

Y1 - 2016

N2 - Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a relatively low concentration, and an antiangiogenic property at a high concentration. Here we investigated the functions of βi 2GPI and nβ2GPI in vascular endothelial growth factor (VEGF)-A-induced endothelial cell proliferation and tube formation. We used noninvasive PET imaging to analyze the in vivo distribution of intravenously injected β2GPI variants in tumor lesions in mice. iβ2GPI was incubated with plasmin to obtain nβ2GPI, and its N-terminal sequence was analyzed. nβ2GPI had at least one other cleavage site upstream of the β2GPI's domain V, whereas the former plasmin-cleavage site locates between K317 and T318. Both of intact and nicked β2GPI significantly inhibited the VEGF-A-induced cell proliferation and the tube formation of human umbilical vein endothelial cells (HUVECs). PET imaging visualized considerably distributed intensities of all tested β2GPI variants in tumor lesions of pancreatic tumor cell-xenografts. These results indicate that β2GPI may be physiologically and pathophysiologically important in the regulation of not only coagulation and fibrinolysis, but also angiogenesis.

AB - Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a relatively low concentration, and an antiangiogenic property at a high concentration. Here we investigated the functions of βi 2GPI and nβ2GPI in vascular endothelial growth factor (VEGF)-A-induced endothelial cell proliferation and tube formation. We used noninvasive PET imaging to analyze the in vivo distribution of intravenously injected β2GPI variants in tumor lesions in mice. iβ2GPI was incubated with plasmin to obtain nβ2GPI, and its N-terminal sequence was analyzed. nβ2GPI had at least one other cleavage site upstream of the β2GPI's domain V, whereas the former plasmin-cleavage site locates between K317 and T318. Both of intact and nicked β2GPI significantly inhibited the VEGF-A-induced cell proliferation and the tube formation of human umbilical vein endothelial cells (HUVECs). PET imaging visualized considerably distributed intensities of all tested β2GPI variants in tumor lesions of pancreatic tumor cell-xenografts. These results indicate that β2GPI may be physiologically and pathophysiologically important in the regulation of not only coagulation and fibrinolysis, but also angiogenesis.

KW - Angiogenesis

KW - Positron emission tomography (PET) imaging

KW - Vascular endothelial growth factor-A (VEGF-A)

KW - β2-glycoprotein I (β2GPI)

UR - http://www.scopus.com/inward/record.url?scp=84962212122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962212122&partnerID=8YFLogxK

M3 - Article

C2 - 26899605

AN - SCOPUS:84962212122

VL - 70

SP - 13

EP - 24

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 1

ER -